SCHEDULE: Aberdeen Group plc Reports 7.49% Stake in InspireMD

Aberdeen Group plc and abrdn Inc. have reported a shared beneficial ownership of 7.49% of InspireMD, Inc.'s common stock.

Summary

• Aberdeen Group plc and its subsidiary abrdn Inc. have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in InspireMD, Inc.
• The reporting persons collectively beneficially own 3,173,364 shares of InspireMD, Inc. common stock.
• This ownership represents 7.49% of the total class of securities.
• Both Aberdeen Group plc and abrdn Inc. hold shared voting power and shared dispositive power over all 3,173,364 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an institutional investor and does not contain performance or strategic updates for the issuer.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership stakes, which can influence market perception and liquidity for companies like InspireMD, Inc. This type of disclosure is standard for large asset managers to report their passive investment positions.

Stakeholder Impact

• Increased transparency for shareholders regarding significant institutional ownership.
• Potential for increased investor confidence due to institutional backing.

Key Dates

Keywords

InspireMD, Aberdeen Group plc, abrdn Inc., Schedule 13G, beneficial ownership, common stock, institutional ownership, equity stake